Can we expect decreasing the incidence of patent ductus arteriosus (PDA) in the population of premature neonates who had received antenatal steroid therapy?;Czy u wcześniaków poddanych prenatalnej steroidoterapii mozna spodziewac sie ograniczenia czestości wystepowania przetrwałego przewodu tetniczego (PDA)?

Ginekologia polska

Volumn 76, Issue 10, 2005, Pages 812-818

  Kesiak, Marcin ^a   Nowiczewski, Marek ^a   Gulczyńska, Ewa ^a   Kasprzak, Elzbieta ^a   Binikowska, Jolanta ^a   Gadzinowski, Janusz ^a  

^a Kliniki Neonatologii ICZMP ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METHODOLOGY; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; RETROSPECTIVE STUDY;

ADULT; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL CARE; RETROSPECTIVE STUDIES;

EID: 33644869862     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)